News and Updates

Date:
July 14, 2016

SRT – The Best Keloid Scar Treatment!

SRT is the best keloid scar treatment on the market.

Keloids form after the skin has been injured and the growth of fibrous tissue, more commonly known as scar tissue, begins to grow excessively. These unsightly, smooth, yet hard colonies of scar tissue are found mostly on the shoulders, cheeks, earlobes, and chest but can affect any part of the body. A keloid scar can form from the healing sties of chickenpox, acne scars, piercings, incisions, vaccinations or even scratches. These aberrations of the skin may take weeks or months to fully form and have a higher chance of affecting people with African, Latino or Asian heritage, pregnant women and people younger than 30 years old. Up until now, there has not been a non-invasive form of treatment to rid you of your keloids, but we have an acronym for you.

SRT stands for Superficial Radio Therapy. The SRT has an astonishing long term cure rate of 86% for keloid patients. The Superficial Radio Therapy only goes skin deep and forfeits the need for many components and aspects associated with traditional keloid scar treatment such as:

  • No cutting
  • No stitching
  • No risk of infection or scarring
  • No use of anesthesia
  • No pain or need for reconstructive cosmetic surgery

The success of this technology is unprecedented, as there have been other surgical strategies to combat keloids, but the SRT-100™ prevails where other methods have failed. In the past, traditional surgery has been successful in removing keloids, but in ninety percent of cases, the keloid would grow back. The SRT-100™ has halted the reoccurrence rate of keloid growth to only ten percent and zero percent in others. Fortunately for you, the SRT-100™ is just a click away, so contact us today if you are looking for the best keloid scar treatment the market has to offer.

ELEVATING DERMATOLOGICAL CARE

Stay connected with Sensus Healthcare for more news and updates. For inquiries or further information, please contact us.